The positive predictive value of ct-proAVP (copeptin) in patients with STEMI

Heart

Volumn 99, Issue 20, 2013, Pages 1475-

  Möckel, Martin ^a   Searle, Julia ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; COPEPTIN; TROPONIN;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; CARDIOVASCULAR MAGNETIC RESONANCE; EDITORIAL; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; MAXIMUM TOLERATED DOSE; NONHUMAN; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANIMALS; ELECTROCARDIOGRAPHY; GLYCOPEPTIDES; HEART VENTRICLES; HUMANS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; VASOPRESSINS; VENTRICULAR REMODELING;

EID: 84884592963     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304217     Document Type: Editorial

References (11)

1. Reinstadler SJ, Klug G, Feistritzer HJ, et al. Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction. Heart 2013;99:1254-8.
2. Morgenthaler NG, Struck J, Alonso C, et al. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006;52:112-19.
3. Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010;55:2096-106.
4. Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009;54:60-8.
5. Giannitsis E, Kehayova T, Vafaie M, et al. Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non ST-segment elevation myocardial infarction. Clin Chem 2011;57:1452-5.
6. Maisel A, Mueller C, Neath SX, et al. Copeptin helps copeptin helps in the early detection of patients with acute myocardial infarction: the primary results of the CHOPIN Trial. J Am Coll Cardiol 2013;62:150-60.
7. Wu AHB, Tabas JA, Vollert JO, et al. Results of novel cardiac biomarkers in Tako-Tsubo cardiomyopathy. Int J Cardiol 2012;159:53-5.
8. Maisel A, Xue Y, Shah K, et al. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ Heart Fail 2011;4:613-20.
9. Peacock WF, Nowak R, Christenson R, et al. Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med 2011;18:947-58.
10. Liebetrau C, Nef H, Szardien S, et al. Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem 2013;59:566-9.
11. Hupf H, Grimm D, Riegger GAJ, et al. Evidence for a vasopressin system in the rat heart. Circ Res 1999;84:365-70.